EP0370413B1 - Schuheinlegesohle - Google Patents
Schuheinlegesohle Download PDFInfo
- Publication number
- EP0370413B1 EP0370413B1 EP89121368A EP89121368A EP0370413B1 EP 0370413 B1 EP0370413 B1 EP 0370413B1 EP 89121368 A EP89121368 A EP 89121368A EP 89121368 A EP89121368 A EP 89121368A EP 0370413 B1 EP0370413 B1 EP 0370413B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- insole
- shoe
- shoe insole
- chambers
- natural
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000004816 latex Substances 0.000 claims abstract description 8
- 229920000126 latex Polymers 0.000 claims abstract description 8
- 239000011888 foil Substances 0.000 claims abstract description 4
- 239000002184 metal Substances 0.000 claims abstract description 4
- 239000004065 semiconductor Substances 0.000 claims abstract description 3
- 239000011149 active material Substances 0.000 claims abstract 2
- 239000013543 active substance Substances 0.000 claims description 4
- 239000005445 natural material Substances 0.000 claims description 4
- 150000001875 compounds Chemical group 0.000 claims description 3
- 239000000956 alloy Substances 0.000 claims description 2
- 229910045601 alloy Inorganic materials 0.000 claims description 2
- 239000004033 plastic Substances 0.000 claims description 2
- 229920003023 plastic Polymers 0.000 claims description 2
- 239000000419 plant extract Substances 0.000 claims 1
- 239000000463 material Substances 0.000 abstract description 21
- 230000000694 effects Effects 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 239000000835 fiber Substances 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 230000011514 reflex Effects 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 210000003491 skin Anatomy 0.000 description 4
- 235000013616 tea Nutrition 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 239000004744 fabric Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 210000002268 wool Anatomy 0.000 description 3
- 240000000467 Carum carvi Species 0.000 description 2
- 240000006927 Foeniculum vulgare Species 0.000 description 2
- 244000246386 Mentha pulegium Species 0.000 description 2
- 235000016257 Mentha pulegium Nutrition 0.000 description 2
- 235000004357 Mentha x piperita Nutrition 0.000 description 2
- 206010034568 Peripheral coldness Diseases 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 238000001467 acupuncture Methods 0.000 description 2
- 229940070641 chamomile flowers Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 235000001050 hortel pimenta Nutrition 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000012209 synthetic fiber Substances 0.000 description 2
- 229920002994 synthetic fiber Polymers 0.000 description 2
- 244000198134 Agave sisalana Species 0.000 description 1
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 description 1
- 235000003097 Artemisia absinthium Nutrition 0.000 description 1
- 240000002877 Artemisia absinthium Species 0.000 description 1
- 240000001851 Artemisia dracunculus Species 0.000 description 1
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 235000005747 Carum carvi Nutrition 0.000 description 1
- 241000501711 Centaurium Species 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- 244000183685 Citrus aurantium Species 0.000 description 1
- 235000007716 Citrus aurantium Nutrition 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 240000005636 Dryobalanops aromatica Species 0.000 description 1
- 241000402754 Erythranthe moschata Species 0.000 description 1
- 244000004281 Eucalyptus maculata Species 0.000 description 1
- 235000004204 Foeniculum vulgare Nutrition 0.000 description 1
- 208000002655 Foot Dermatoses Diseases 0.000 description 1
- 208000014770 Foot disease Diseases 0.000 description 1
- 241001071795 Gentiana Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 244000126014 Valeriana officinalis Species 0.000 description 1
- 235000013832 Valeriana officinalis Nutrition 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 238000004026 adhesive bonding Methods 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 239000001138 artemisia absinthium Substances 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 238000009795 derivation Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000002631 hypothermal effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000015091 medicinal tea Nutrition 0.000 description 1
- 239000002923 metal particle Substances 0.000 description 1
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000000276 sedentary effect Effects 0.000 description 1
- 229940076742 senna leaves Drugs 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 239000012815 thermoplastic material Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000016788 valerian Nutrition 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
- 239000009637 wintergreen oil Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A43—FOOTWEAR
- A43B—CHARACTERISTIC FEATURES OF FOOTWEAR; PARTS OF FOOTWEAR
- A43B17/00—Insoles for insertion, e.g. footbeds or inlays, for attachment to the shoe after the upper has been joined
- A43B17/14—Insoles for insertion, e.g. footbeds or inlays, for attachment to the shoe after the upper has been joined made of sponge, rubber, or plastic materials
-
- A—HUMAN NECESSITIES
- A43—FOOTWEAR
- A43B—CHARACTERISTIC FEATURES OF FOOTWEAR; PARTS OF FOOTWEAR
- A43B7/00—Footwear with health or hygienic arrangements
- A43B7/14—Footwear with health or hygienic arrangements with foot-supporting parts
- A43B7/1405—Footwear with health or hygienic arrangements with foot-supporting parts with pads or holes on one or more locations, or having an anatomical or curved form
- A43B7/1455—Footwear with health or hygienic arrangements with foot-supporting parts with pads or holes on one or more locations, or having an anatomical or curved form with special properties
- A43B7/1464—Footwear with health or hygienic arrangements with foot-supporting parts with pads or holes on one or more locations, or having an anatomical or curved form with special properties with adjustable pads to allow custom fit
Definitions
- the invention relates to a shoe insole made of synthetic or natural materials, preferably made of non-porous latex and other materials for the top and bottom.
- the resulting long-term hypothermia of the foot can now damage health: due to the liquid film that has existed for a long time, the tissue of the epidermis is attacked in such a way that it is particularly susceptible to mycoses. On the other hand, it is also so weakened that eczema can develop, allergies are observed less frequently. It is therefore not surprising that, according to current estimates, the majority of all residents of our latitudes suffer from some kind of foot dermatosis, i.e. from an infectious foot disease.
- US-A-2 713 215 relates to a shoe insole provided with a powdered drug. This contains two pockets with pillows made of a sponge-like material, which serve as a drug carrier and are arranged under the ball or toe area and under the arch of the foot.
- US-A-2 911 973 relates to an agent for administering foot powder, which is designed as an insert or insole and continuously supplies the feet with the powder while walking.
- This medium has a bag-like structure made of an upper layer made of a deformable porous material and a lower layer made of a preferably thermoplastic material which is impermeable to the foot powder.
- GB-A-1 547 144 describes a shoe insole made of two layers of braid which are sealed at the edges to form an internal cavity which can hold a certain amount of powder.
- FR-A-749 193 describes the utilization of a galvanic element in shoes for medicinal electrification as well as for heating the feet.
- the present invention is intended to provide a shoe insole which not only enables a perfect water vapor exchange combined with appropriate thermal insulation, but also guarantees better blood circulation in the sole of the foot, massages and irritates the overlying tissue at certain acupuncture points or in the known reflex zones and meridians. forms and supports the foot.
- a shoe insole made of plastic or natural materials, preferably made of non-porous latex, with chambers and cavities 4 and 4 'which contain physiologically active substances and are closed by covers 6 and 7 on the top and bottom, the different Large chambers of the inner scaffold of the sole consist of support webs 2 and 2 'which may have different strengths, at the intersection points of which knob-like or rib-like elevations 9 are formed.
- the load-bearing frame of the shoe insole hereinafter referred to as insole for short, comprises a 5 mm high frame made of a suitable material, e.g. B. from 3 - 6 mm latex or a similar material. It is sufficient, but also stiff enough to provide effective support for the various foot shapes thanks to its anatomically shaped surface. The material can absorb a pressure of approx. 1.5 - 3.5 N / mm without being irreversibly deformed.
- the load-bearing webs of the scaffold which can be arranged in a wide variety of ways, are used for the uniform derivation of dynamic and static pressures in this Are of the order of magnitude and for an inventive special purpose, which will be described below.
- knobs at their crossing points. These elevations massage the entire bottom of the foot.
- the above-mentioned webs of the insole which virtually represent a framework, form a cavity within the sole with one another and with the edge of the insole, which can have different volumes and the most varied shapes.
- the cavities that are delimited by the webs can delimit large areas of the insole, but also small ones that correspond to so-called reflex zones of the sole of the foot or that combine several such reflex zones.
- the main zones of this insole are mainly in the heel, instep and toe areas in the form of webs from z. B. pore-free latex, which converge at one point so that they form a punctiform or rib-shaped elevation. At these points, comparable to the acupuncture points and / or meridians, a special irritation and massage are inevitably exerted on the foot tissue above.
- the top and bottom of the insole are each air-permeable by fibers made of natural materials, these can be fleece, fabric, or knitted fabric z. B. from sisal or coconut fibers. If desired and applicable, the underside and the top of the shoe sole can also be covered from a material made of synthetic fibers or from a material which contains synthetic and natural fibers as a mixture.
- the bottom layer of this insole can also be a perforated or closed metal foil or contain one, so that it controls the desired convection currents in the foot space delimited by the shoe.
- the metal foil can be equipped with a wide variety of metal particles, for example with germanium or other analog semiconductor particles, and / or can form a total of their alloys or compounds.
- the top layer of the insole is a natural material.
- This natural fabric can also be in the form of natural fibers such as wool, cotton or a suitable piece of fur.
- virgin wool that has not yet been degreased has a significant capacity for absorbing condensation, which can be up to a quarter of the weight of the virgin wool used.
- the cavities or chambers of the framework of the insole which are formed by the intersecting and connected webs, for example made of latex, and which are covered on the top and bottom as described above, are filled with physiologically relevant specialties which can now act on the organism in a selectable manner.
- medicinally effective specialties are now in powder, granule, leaf, tablet, etc. form. so filled into the chambers described above that they are available over a long period of time in the small climate of footwear that is favorable for this type of application and can therefore be used. Since there is little free air volume in the footwear and this is filled to a finite amount with a suitably tempered water vapor, the effectiveness of the specialties is guaranteed, which have a finite vapor pressure and can react both lipophilic and hydrophilic. This does not only apply to fragrances such as Musk or for organic substances that have a relatively high vapor pressure, such as. B. camphor, wintergreen oil, eucalyptus, but with medicinal teas, that is, for medicinal plant parts, but also for trace elements, which can be mixed with the teas or medicinal plant parts such as leaves. Chemical, relevant compounds can also be included.
- Spray-dried products are advantageous according to the invention because high concentrations can be accommodated in the limited spaces or chambers.
- a spray-dried tea extract is therefore a cheap form of application.
- teas listed above are only examples of active ingredients which, individually or in a mixture with other active ingredients, can be broken, pressed or selected as spray-dried extract or spray-dried material in the cavities of the insole described above, that is, taking into account those mentioned above Reaction zones attached to the sole of the foot and, due to the special type and arrangement of the insole, act on the human body.
- the invention has been described in the above description in its application to an insole that can be worn in normal and everyday footwear. However, the invention is just as effective, even more effective if it has the shape and arrangement of a shoe sole on a slipper like the one worn in the house, clinics, saunas or spa centers.
- the insole would meet the criteria of the above invention, would only be of a larger volume, and would be made of a material that would suit this application.
- a slipper made of woven or knitted or fur-like upper material the sole of which is provided with an inner frame, the chambers or cavities are large, however, and the material of the insole does not have to be necessary durability as in a street shoe.
- the use of such a shoe, which could be called a slipper or spa shoe, would have the advantage that it could be combined with treatment measures.
- the invention is more effective because there is no need to wear the stockings.
- spa guests with limited activities spend their stay in a spa center or in a sanatorium, in which slippers are mainly worn because one spends a long time indoors.
- the shoe can also have the shape of a so-called “slipper” or a “slipper”.
- reference numeral 1 denotes the insole, which consists of a frame with webs 2 and edge 3, which are connected to one another and form chambers 4, which are filled with the most physiologically effective specialties in the form of plant parts or extracts.
- the edge 5 is the connecting edge between the cover 6 of the top and the cover 7 of the bottom.
- the edge 5 can of course also be omitted in that the edge 3 is laid further outwards or the edge 5, which can be referred to as the quilted edge, can be glued upwards from the outside against the edge 3.
- the cover 6 above and below 7 is made of the materials mentioned in the description.
- FIG. 3 shows a further possibility of producing and designing an insole according to the invention.
- webs 2 are available in a wide variety of lengths and arrangements, which now form chambers 4 'in a wide variety of shapes and sizes, so it can be seen that there are larger chambers in the toe area of the sole than in the middle area and in the heel area at 8.
- the arrangement of these walls must be adapted to the intended use of the insole.
- large and small chambers can be combined and particularly strong webs as shown at 2 'and thin webs as at reference number 2.
- nub-like or rib-like elevations can be made, as indicated at 10 and 11. These elevations serve the mechanical impact on the sole of the foot.
- the material 6 for the upper side and that for the lower side 7 is fastened to the framework of the sole, which is formed by the partition walls of the chambers in connection with the outer edge 12, for example by gluing or welding.
- the upper cover 6 can be a fur-like natural material in FIG. 4.
- the framework of the insole can consist of a suitable latex, which ensures both the required strength and the stability of the sole in itself.
- 5 are known reflex zones which can be influenced by the design of the insole according to the invention.
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Footwear And Its Accessory, Manufacturing Method And Apparatuses (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT89121368T ATE92726T1 (de) | 1988-11-25 | 1989-11-18 | Schuheinlegesohle. |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3839747A DE3839747A1 (de) | 1988-11-25 | 1988-11-25 | Schuheinlegesohle |
DE3839747 | 1988-11-25 |
Publications (3)
Publication Number | Publication Date |
---|---|
EP0370413A2 EP0370413A2 (de) | 1990-05-30 |
EP0370413A3 EP0370413A3 (en) | 1990-07-18 |
EP0370413B1 true EP0370413B1 (de) | 1993-08-11 |
Family
ID=6367836
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP89121368A Expired - Lifetime EP0370413B1 (de) | 1988-11-25 | 1989-11-18 | Schuheinlegesohle |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0370413B1 (enrdf_load_stackoverflow) |
AT (1) | ATE92726T1 (enrdf_load_stackoverflow) |
DE (2) | DE3839747A1 (enrdf_load_stackoverflow) |
ES (1) | ES2014384T3 (enrdf_load_stackoverflow) |
GR (2) | GR910300021T1 (enrdf_load_stackoverflow) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10619296B2 (en) | 2017-01-06 | 2020-04-14 | Under Armour, Inc. | Articles with embroidered sequins and methods of making |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH679442A5 (enrdf_load_stackoverflow) * | 1989-08-14 | 1992-02-28 | Flawa Schweiz Verband Wattefab | |
DE4202159A1 (de) * | 1992-01-27 | 1993-07-29 | Naima Bouzahar | Einlegesohle bzw. innensohle fuer schuhe aus sandfuellung |
DE4446252A1 (de) * | 1994-01-18 | 1995-06-22 | Klaus Peter Jaehnke | Anpassungs-Einlegesohle |
DE4406063A1 (de) * | 1994-02-24 | 1995-08-31 | Prodomo Sa | Einlegesohle |
RU2217026C2 (ru) * | 2001-08-02 | 2003-11-27 | Московский государственный университет дизайна и технологии | Вкладная стелька |
EP3082489B1 (en) * | 2013-12-20 | 2022-04-20 | Medicovi ApS | Balance-improving liquid-filled insole for use in therapeutics, rehabilitation, standing and walking work and sports |
KR102104571B1 (ko) | 2015-09-24 | 2020-04-27 | 나이키 이노베이트 씨.브이. | 코팅된 유지체 내의 입자형 발포체 |
EP4272596A3 (en) | 2019-07-25 | 2024-01-24 | NIKE Innovate C.V. | Article of footwear |
WO2021016189A1 (en) | 2019-07-25 | 2021-01-28 | Nike Innovate C.V. | Article of footwear |
WO2021016199A1 (en) | 2019-07-25 | 2021-01-28 | Nike Innovate C.V. | Cushioning member for article of footwear |
CN110547964B (zh) * | 2019-08-28 | 2021-09-10 | 苏州皇宫绣量子科技有限公司 | 一种具有足疗功能的平衡鞋垫及其工作方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR749193A (fr) * | 1933-01-18 | 1933-07-20 | Semelle galvanique curative et chauffant? | |
US2713215A (en) * | 1953-08-20 | 1955-07-19 | Bernard J Cosneck | Medicated insole |
US2911973A (en) * | 1955-06-20 | 1959-11-10 | Rocco L Chieffo | Innersole |
GB1547144A (en) * | 1978-01-12 | 1979-06-06 | Fong Gin Sung | Inner sole for a shoe |
DE3145463C2 (de) * | 1981-11-16 | 1984-06-07 | LECO Gesundheitshilfen GmbH & Co KG, 7921 Gerstetten | Einlage für Schuhwerk |
DE3627538A1 (de) * | 1986-08-13 | 1988-02-18 | Alfred Fleischmann | Innensohle fuer schuhe, insbesondere einlegesohle |
-
1988
- 1988-11-25 DE DE3839747A patent/DE3839747A1/de not_active Ceased
-
1989
- 1989-11-18 AT AT89121368T patent/ATE92726T1/de not_active IP Right Cessation
- 1989-11-18 DE DE8989121368T patent/DE58905259D1/de not_active Expired - Fee Related
- 1989-11-18 EP EP89121368A patent/EP0370413B1/de not_active Expired - Lifetime
- 1989-11-18 ES ES89121368T patent/ES2014384T3/es not_active Expired - Lifetime
-
1991
- 1991-11-15 GR GR91300021T patent/GR910300021T1/el unknown
-
1993
- 1993-10-31 GR GR930300081T patent/GR930300081T1/el unknown
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10619296B2 (en) | 2017-01-06 | 2020-04-14 | Under Armour, Inc. | Articles with embroidered sequins and methods of making |
US11149382B2 (en) | 2017-01-06 | 2021-10-19 | Under Armour, Inc. | Articles with embroidered sequins in variable patterns |
US11332882B2 (en) | 2017-01-06 | 2022-05-17 | Under Armour, Inc. | Articles with embroidered sequins and methods of making |
US11359333B2 (en) | 2017-01-06 | 2022-06-14 | Under Armour, Inc. | Articles with structures formed from sequins |
US12398511B2 (en) | 2017-01-06 | 2025-08-26 | Under Armour, Inc. | Articles with embroidered sequins in variable patterns |
Also Published As
Publication number | Publication date |
---|---|
ES2014384T3 (es) | 1994-01-01 |
GR910300021T1 (en) | 1991-11-15 |
DE3839747A1 (de) | 1990-05-31 |
EP0370413A2 (de) | 1990-05-30 |
GR930300081T1 (enrdf_load_stackoverflow) | 1993-10-31 |
DE58905259D1 (de) | 1993-09-16 |
ATE92726T1 (de) | 1993-08-15 |
EP0370413A3 (en) | 1990-07-18 |
ES2014384A4 (es) | 1990-07-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0370413B1 (de) | Schuheinlegesohle | |
EP0558897B1 (de) | Einlegesohle | |
EP1341495B1 (de) | Schuh mit fussmassierender wirkung | |
DE3627538C2 (enrdf_load_stackoverflow) | ||
DE69430956T2 (de) | Flüssigkeitsgefüllte einlegesohle | |
EP1721536B1 (de) | Massagesohle für einen Schuh | |
DE4202159A1 (de) | Einlegesohle bzw. innensohle fuer schuhe aus sandfuellung | |
CN105535293A (zh) | 一种保健足贴及其外敷药物粉末 | |
DE10158286B4 (de) | Wirkstoffspeicherndes Schichtmaterial | |
WO2017045663A1 (de) | Medizinisches pflaster | |
DE10141568C2 (de) | Schuh mit fußmassierender Wirkung | |
EP0791303A2 (de) | Einlagesohle | |
CN201025924Y (zh) | 透气药物鞋垫 | |
CN208064609U (zh) | 复合保健鞋垫 | |
DE69928629T2 (de) | Fluidgefüllte Einlegesohle | |
EP0925747A1 (de) | Auflage für eine Matratze | |
AT506213B1 (de) | Strumpfförmige fussanpassung | |
DE102006023076B4 (de) | Belüftungssystem für Schuhe oder Strümpfe | |
DE929595C (de) | Zehenschuetzer | |
DE202007000993U1 (de) | Schuheinlegesohlen | |
DE3610849A1 (de) | Schuheinlegesohle | |
DE202011109917U1 (de) | Massagevorrichtung | |
DE10126577C2 (de) | Verwendung von Algenblättern zur Herstellung von Körperumschlägen sowie Vorprodukt dafür | |
DE20107532U1 (de) | Mittel zur Behandlung und/oder Verhütung von Fußpilz | |
CN2507481Y (zh) | 绿色中草药保健鞋垫 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE CH DE ES FR GB GR IT LI LU NL SE |
|
PUAL | Search report despatched |
Free format text: ORIGINAL CODE: 0009013 |
|
ITCL | It: translation for ep claims filed |
Representative=s name: DE DOMINICIS & MAYER S.R.L. |
|
GBC | Gb: translation of claims filed (gb section 78(7)/1977) | ||
TCNL | Nl: translation of patent claims filed | ||
AK | Designated contracting states |
Kind code of ref document: A3 Designated state(s): AT BE CH DE ES FR GB GR IT LI LU NL SE |
|
EL | Fr: translation of claims filed | ||
17P | Request for examination filed |
Effective date: 19910109 |
|
17Q | First examination report despatched |
Effective date: 19920730 |
|
ITF | It: translation for a ep patent filed | ||
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE CH DE ES FR GB GR IT LI LU NL SE |
|
REF | Corresponds to: |
Ref document number: 92726 Country of ref document: AT Date of ref document: 19930815 Kind code of ref document: T |
|
GBT | Gb: translation of ep patent filed (gb section 77(6)(a)/1977) |
Effective date: 19930810 |
|
REF | Corresponds to: |
Ref document number: 58905259 Country of ref document: DE Date of ref document: 19930916 |
|
ET | Fr: translation filed | ||
REG | Reference to a national code |
Ref country code: GR Ref legal event code: FG4A Free format text: 3009548 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2014384 Country of ref document: ES Kind code of ref document: T3 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: BE Payment date: 19940104 Year of fee payment: 5 |
|
EPTA | Lu: last paid annual fee | ||
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed | ||
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Effective date: 19941130 |
|
EAL | Se: european patent in force in sweden |
Ref document number: 89121368.8 |
|
BERE | Be: lapsed |
Owner name: KEHLBECK HEINRICH Effective date: 19941130 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GR Payment date: 19961129 Year of fee payment: 8 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: LU Payment date: 19961130 Year of fee payment: 8 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 19971106 Year of fee payment: 9 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 19971107 Year of fee payment: 9 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: ES Payment date: 19971110 Year of fee payment: 9 Ref country code: CH Payment date: 19971110 Year of fee payment: 9 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: AT Payment date: 19971112 Year of fee payment: 9 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: SE Payment date: 19971113 Year of fee payment: 9 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19971118 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19971130 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 19971130 Year of fee payment: 9 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 19971231 Year of fee payment: 9 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19981118 Ref country code: AT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19981118 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19981119 Ref country code: ES Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 19981119 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19981130 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19981130 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19990601 |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 19981118 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19990730 |
|
EUG | Se: european patent has lapsed |
Ref document number: 89121368.8 |
|
NLV4 | Nl: lapsed or anulled due to non-payment of the annual fee |
Effective date: 19990601 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19990901 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FD2A Effective date: 20010301 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES;WARNING: LAPSES OF ITALIAN PATENTS WITH EFFECTIVE DATE BEFORE 2007 MAY HAVE OCCURRED AT ANY TIME BEFORE 2007. THE CORRECT EFFECTIVE DATE MAY BE DIFFERENT FROM THE ONE RECORDED. Effective date: 20051118 |